Get started
Author

Raquel Cuesta

Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes
2012 · Lídia Feliubadaló, Adriana Lopez-Doriga, et al. · European Journal of Human Genetics · 111
Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients
2020 · Jesús del Valle, Paula Rofes, et al. · Cancers · 85
PDF
Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes
2009 · Jesús del Valle, Lídia Feliubadaló, et al. · Breast Cancer Research and Treatment · 39
PDF
Immunocytokines and cytokine neutralization for cancer immunotherapy
2025 · Pedro Berraondo, Raquel Cuesta, et al. · Trends in cancer · 21
BARD1 Pathogenic Variants Are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort
2021 · Paula Rofes, Jesús Del Valle, et al. · Genes · 21
PDF
Immunogenicity and Efficacy of Personalized Adjuvant mRNA Cancer Vaccines
2024 · Pedro Berraondo, Raquel Cuesta, et al. · Cancer Discovery · 19
Comprehensive analysis and ACMG‐based classification of CHEK2 variants in hereditary cancer patients
2020 · Gardenia Vargas‐Parra, Jesús Valle, et al. · Human Mutation · 16
PDF
Screening of CNVs using NGS data improves mutation detection yield and decreases costs in genetic testing for hereditary cancer
2020 · José Marcos Moreno-Cabrera, Jesús del Valle, et al. · Journal of Medical Genetics · 11
Mosaicism in PTEN—new case and comment on the literature
2022 · Paula Rofes, Álex Teulé, et al. · European Journal of Human Genetics · 7
PDF
Elucidating the clinical significance of two PMS2 missense variants coexisting in a family fulfilling hereditary cancer criteria
2017 · Maribel González-Acosta, Jesús del Valle, et al. · Familial Cancer · 7
ICO Amplicon NGS Data Analysis: A Web Tool for Variant Detection in Common High-Risk Hereditary Cancer Genes Analyzed by Amplicon GS Junior Next-Generation Sequencing
2013 · Adriana Lopez-Doriga, Lídia Feliubadaló, et al. · Human Mutation · 2
T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody
2026 · Carlos Luri-Rey, Inmaculada Rodríguez, et al. · Immunity · 1
PDF
Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al. · Cancer Research · 1
Monomethyl-auristatin E-based anti-CD137 (4-1BB) antibody drug conjugates are not suitable tools to deplete activated T lymphocytes
2026 · Gabriel Gomis, Saioa Arrieta-Aranzueque, et al. · Immunobiology · 1
Optimizing GRIDSS for clinical use: A targeted NGS filtering strategy for germline structural variant detection
2026 · Elisabet Munté, Paula Rofes, et al. · European Journal of Human Genetics · 1
PDF
Supplementary Fig. S7 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al.
Supplementary Fig. S3 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al.
Supplementary Fig. S1 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al.
Supplementary Fig. S2 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al.
Supplementary Fig. S5 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al.
Supplementary Fig. S11 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al.
Supplementary Fig. S4 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al.
Supplementary Fig. S10 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al.
Supplementary Fig. S9 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al.
Data from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026 · Gabriel Gomis, Claudia Herrero, et al.
Works count: 29
Citation count: 343
H-index: 8
I10-index: 8
Year
Topic
Type